Archive for the ‘Injectables’ Category

Over 100,000 Registered for Dysport Challenge

Sunday, August 8th, 2010 by editor2

injection into frown linesThe maker of the wrinkle treatment Dysport announced that over 100,000 people have registered for the  Dysport Challenge. The challenge, which began in March, allows patients to save $75 when they try Dysport. If they “love it,” patients may receive $75 off their next Dysport treatment; if they don’t, patients receive a $75 rebate off another botulinum toxin type A product, such as Botox.

Between March 1 and May 9, 2010, 91.2 percent of 22,416 patients who made a selection chose “Love It,” according to Medicis, the maker of Dysport.

So far, only 2.6 percent of all registered patients have made a selection to “Leave It” since the program began.

Dysport was approved by the FDA in April 2009 to treat severe frown lines between the eyebrows—the first competitor to Botox in the U.S.

Dysport works by blocking the nerve impulses of tiny muscles that cause wrinkles in the face, allowing them to flatten out and become less visible.

“We are pleased to announce this tremendous support by both physicians and patients for the Dysport Challenge,” said Jonah Shacknai, Chairman and Chief Executive Officer of Medicis. “Medicis made a bold statement of confidence in the brand by offering patients the opportunity to try Dysport and save up to $150 total.”

The Dysport Challenge runs through the end of September 2010 and is open to patients 18 and older. For complete challenge details, visit www.DysportUSA.com. Dr. Branman offers Dysport at his Cosmetic Surgery Center in Little Rock, Arkansas .

Tags:
Posted in In the News, Injectables | No Comments »

Injectable Advancement Means Less Pain for Patients

Monday, June 21st, 2010 by editor2

The July 2010 issue of Cosmetic Surgery Times reports that the U.S. injectables market now offers lidocaine-containing versions of popular hyaluronic acid (HA) fillers. Lidocaine is a local anesthetic that is injected directly into the body area and decreases pain by temporarily numbing that area, according to WebMD.

Three injectables won FDA approval in February 2010 for lidocaine versions in the U.S.:

Dr. Michael H. Gold, a clinical assistant professor of dermatology at Vanderbilt University School of Medicine and School of Nursing, says the products performed similarly to their lidocaine-free predecessors in terms of efficacy and safety.

Furthermore, in the clinical trials, he says, “The incorporation of lidocaine has surely provided a higher comfort level for patients.”

Based on his clinical experience, Dr. Gold says when undergoing an injection that includes even a small percentage of lidocaine, “Most patients say they barely feel the second stick. To me that is the home run of lidocaine in these fillers.”

In the 72-patient trial of Juvederm XC, patients were blindfolded and their nasolabial folds were treated with either Juvederm or Juvederm XC. Patients assessed pain levels during treatment and then 30 minutes and 24 hours post-treatment. In the study, 93 percent reported less pain when treated with the lidocaine formulation versus the non-lidocaine formulation of Juvéderm.

The FDA also cleared a method for doctors mixing lidocaine with Radiesse in July 2009. “Originally, I was against doctors mixing a lot of fillers because I was afraid of potential changes in the products themselves,” says Dr. Gold. But once the FDA clears these products, especially those premixed by manufacturers, “I’m pretty comfortable with it.”
Both Juvederm and Restylane are offered at Dr. Branman’s Little Rock office.

Read the full story from Cosmetic Surgery Times: “Fillers with lidocaine among latest injectable advancements.”

Tags: , ,
Posted in In the News, Injectables | No Comments »

A New Skincare Line from the Makers of Restylane

Monday, April 12th, 2010 by newseditor

Q-Med, maker of Restylane and Perlane, just announced their new line of skincare Restylane_littlerockproducts at the World Congress for Anti-Aging Medicine in Monaco.

The new line of products contain the same patented NASHA technology used in Restylane injectable filler, an addition that provides a pleasing consistency while preserving moisture and adding luster to the skin.

In a press release, Q-Med explained their intentions with the new skincare line: “The secret to beautiful skin is balanced skin hydration combined with a healthy and protective skin barrier. Restylane Skincare combines these two qualities in an innovative series of creams [that] supplement the effect of injectable Restylane products.”

What is NASHA?

Non-Animal Stabilized Hyaluronic Acid is the secret to Restylane’s success. Hyaluronic acid serves many important functions and in many areas of your body. Because it can bind water, HA hydrates the skin and lubricates the joints. The stabilization process allows Restylane to produce enduring results.

While Restylane and Perlane have been around longer than most wrinkle fillers, they are not the only products containing HA. Products like Prevelle, Hydrelle and others are now widely available for similar purposes. However, according to Q-Med, these fillers are not interchangeable with Restylane.

The least modified competing products are still considerably more chemically changed than the NASHA gels. Competing products are either not as viscous as the NASHA gels, which means that they cannot build and retain volume in the same way, or they are considerably more chemically changed.

The new Restylane product line should be available in Sweden and Europe this summer. If they become available here in Little Rock, we will be sure to let you know.

Tags: ,
Posted in Injectables | No Comments »

Celebrity Advice on Juvederm and How to “Switch Up” Your Cosmetic Routine

Monday, March 22nd, 2010 by newseditor

The recently launched Juvederm “Switch Up campaign” combines social networking with a celebrity voice to educate consumers about non-invasive cosmetic enhancements. TV personality Dayna Devon will be providing health, beauty and lifestyle tips via the official Juvederm Facebook page.

Devon has experience with wrinkle fillers, saying she began using them in her 30s, when she “noticed deep lines around [her] nose and mouth that looked like two parentheses.”

To receive useful info from Dayna Devon about fitness, health, beauty and “switching up” your aesthetic routine to look better, become a fan of Juvederm on Facebook.

(more…)

Tags: ,
Posted in Injectables | No Comments »

New Research About Botox and Migraines

Sunday, February 21st, 2010 by newseditor

New research published in Archives of Dermatology supports the conclusion that botox-little-rockBotox can be used to treat migraine headaches.  According to authors of the study, Botox injections “at doses appropriate for cosmetic purposes may be sufficient to prevent migraine attacks.”

Allergan, the pharmaceutical company behind Botox, has filed for FDA approval to market the injectable drug as a migraine treatment.  Researchers don’t know exactly how Botox works to relieve headaches, but one co-author of the study, Rami Burstein tells Bloomberg news: “[Botox] may block the signals in sensory nerves located on the outside of the head.”

Tags: ,
Posted in Injectables | No Comments »

How Lidocaine Enhances Patient Comfort During Cosmetic Injection

Monday, January 25th, 2010 by newseditor

If you’ve considered cosmetic injections, but found yourself hesitating because of botox_little_rockneedles and potential discomfort, you’re not alone. People often expect the injection to hurt, but actually, a number of non-surgical facial procedures can be done with little or no discomfort, thanks to local anesthetics that numb one or more areas of the face.

Lidocaine is the one most frequently used by cosmetic surgeons; there’s no doubt it makes an injectable procedure more comfortable.

Lidocaine works fast

Your dentist uses it as a quick and simple way to numb the mouth prior to dental work. Likewise, surgeons have found that it’s an excellent local anesthetic for use during wrinkle filler injections. Lidocaine blocks the pain signal sent by the nerve endings on the skin in response to injections of the dermal filler solution. Patients quickly feel the anesthetic taking effect, and numbness kicks in.

(more…)

Tags: ,
Posted in Injectables | No Comments »

Botox and Dysport Both Doing Well in Competitive Market

Thursday, November 5th, 2009 by admin

injectables1Allergan and Medicis are showing increased profits this quarter, and analysts are partially attributing the growth to third quarter Botox and Dysport sales.

According to CNN Money , revenues for Dysport manufacturer Medicis last quarter are 30 percent above last year’s figures.  “We are encouraged by the positive physician and patient response to DYSPORT” said Medicis CEO Jonah Shacknai.

While other products may have played a role, Dysport sales were a major factor.  Yet, the new drug still didn’t manage to hurt sales of Botox, the only competitor on the market right now.

Aided by a 3 percent increase in Botox sales, “Allergan’s third quarter profit rose 8.3 percent” reports the Wall Street Journal. New treatment applications are also in the works, which would likely drive sales further.

Although there’s been a positive response to Dysport in Little Rock , the brand awareness of Botox is still a major factor affecting sales, and that probably won’t change anytime soon.

Tags: ,
Posted in Injectables | No Comments »

Quick Contact
First Name

Invalid Input
Last Name

Invalid Input
E-mail (*)

Invalid Input
Security Code
Security Code
  Refresh
Invalid Input
Sign up me for email-only specials?

Invalid Input